LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 48 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $136,000 | +23.6% | 499,932 | +59.4% | 0.00% | – |
| Q2 2022 | $110,000 | -49.5% | 313,703 | -2.5% | 0.00% | – |
| Q1 2022 | $218,000 | -87.0% | 321,603 | -55.7% | 0.00% | – |
| Q4 2021 | $1,678,000 | -49.9% | 726,364 | -0.6% | 0.00% | – |
| Q3 2021 | $3,346,000 | +5.3% | 730,572 | +2.1% | 0.00% | – |
| Q2 2021 | $3,178,000 | -45.4% | 715,782 | -10.5% | 0.00% | – |
| Q1 2021 | $5,822,000 | -3.1% | 799,725 | +1.6% | 0.00% | – |
| Q4 2020 | $6,009,000 | +98.3% | 787,478 | +135.9% | 0.00% | – |
| Q3 2020 | $3,031,000 | +6.6% | 333,842 | -0.7% | 0.00% | – |
| Q2 2020 | $2,844,000 | +81.6% | 336,167 | +6.1% | 0.00% | – |
| Q1 2020 | $1,566,000 | -31.3% | 316,947 | +0.1% | 0.00% | – |
| Q4 2019 | $2,279,000 | -33.8% | 316,531 | -0.6% | 0.00% | – |
| Q3 2019 | $3,442,000 | -4.7% | 318,336 | +14.6% | 0.00% | – |
| Q2 2019 | $3,612,000 | +35.3% | 277,859 | +2.8% | 0.00% | – |
| Q1 2019 | $2,670,000 | +18.9% | 270,271 | +25.2% | 0.00% | – |
| Q4 2018 | $2,245,000 | – | 215,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 8,466,783 | $5,758,000 | 0.09% |
| HARBOR CAPITAL ADVISORS, INC. | 226,731 | $154,000 | 0.07% |
| Sio Capital Management, LLC | 182,630 | $124,000 | 0.04% |
| Virtu Financial LLC | 71,475 | $49,000 | 0.00% |
| Independence Bank of Kentucky | 10,200 | $7,000 | 0.00% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $10,000 | 0.00% |
| Endurance Wealth Management, Inc. | 1,500 | $12,000 | 0.00% |
| Baker Brothers Advisors | 451,478 | $307,000 | 0.00% |
| Texas Yale Capital Corp. | 20,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 79,900 | $54,000 | 0.00% |